The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Open accessAbstract
Acidic extracellular pH (pHe) is a typical attribute of a tumor microenvironment, which has an impact on cancer development and treatment outcome. It was believed to result from an accumulation of lactic acid excessively produced by glycolysis. However, metabolic profiles of glycolysis-impaired tumors have revealed that CO2 is a significant source of acidity, thereby indicating a contribution of carbonic anhydrase (CA). The tumor-associated CA IX isoform is the best candidate, because its extracellular enzyme domain is highly active, expression is induced by hypoxia and correlates with poor prognosis. This study provides the first evidence for the role of CA IX in the control of pHe. We show that CA IX can acidify the pH of the culture medium in hypoxia but not in normoxia. This acidification can be perturbed by deletion of the enzyme active site and inhibited by CA IX-selective sulfonamides, which bind only to hypoxic cells containing CA IX. Our findings suggest that hypoxia regulates both expression and activity of CA IX in order to enhance the extracellular acidification, which may have important implications for tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Švastová and others showed that medium deoxygenation in cell cultures of human cancer cell lines induced the expression and activity of carbonic anhydrases, which resulted in enhanced acidification of the culture medium (Švastová et al., 2004).”
From Toward Best Practices for Controlling Mammalian Cell Culture Environments (2022) · cites this paper as Švastová et al., 2004
Experimental — accuracy not yet measuredIn the citing paper
“Expression of carbonic anhydrases, in particular the CAIX isoform, is elevated during hypoxia (Svastova et al., 2004).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Svastova et al., 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Supuran, C. T., Scozzafava, A., & Casini, A. (2002) · Medicinal Research Reviews · doi:10.1002/med.10025 · Cited by 1,477
Self-citationHypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,260
Self-citationCauses and consequences of tumour acidity and implications for treatment
Stubbs, M., McSheehy, P. M. J., Griffiths, J. R., & Bashford, C. L. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01615-9 · Cited by 781
Acidic pH enhances the invasive behavior of human melanoma cells
Mart�nez-Zaguil�n, R., Seftor, E. A., Seftor, R. E. B., Chu, Y.-W., Gillies, R. J., & Hendrix, M. J. C. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00121214 · Cited by 507
Fukumura, D., Xu, L., Chen, Y., Gohongi, T., Seed, B., & Jain, R. K. (2001) · PubMed · Cited by 438
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., & Jain, R. K. (2002) · PubMed · Cited by 417
Ivanov, S. V., Kuzmin, I., Wei, M.-H., Pack, S., Geil, L., Johnson, B. E., Stanbridge, E. J., & Lerman, M. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12596 · Cited by 394
Opavský, R., Pastoreková, S., Zelnı́k, V., Gibadulinová, A., Stanbridge, E. J., Závada, J., Kettmann, R., & Pastorek, J. (1996) · Genomics · doi:10.1006/geno.1996.0223 · Cited by 383
Self-citationSterling, D., Reithmeier, R. A. F., & Casey, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105959200 · Cited by 367
Carbonic Anhydrase: Its Inhibitors and Activators
Supuran, C. T., Scozzafava, A., & Conway, J. D. (2007) · Medical Entomology and Zoology · Cited by 349
Self-citation
Flagged first, then by citations
1 of the 32 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- Fukumura D., 2001, Cancer Res, 61, 6020
- Helmlinger G., 2002, Clin. Cancer Res, 8, 1284
- Pastorek J., 1994, Oncogene, 9, 2788
- Wykoff C., 2000, Cancer Res, 60, 7075
- 10.1021/jm990479 · DOI
- Semenza G.L., 2003, Nat. Rev, Cancer, 3, 721
- Teicher B.A., 1993, Anticancer Res, 13, 1549
Cited by
Sorted by citations
Items 101–200 of 827
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I–XV
Innocenti, A., Gülçın, İ., Scozzafava, A., & Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.038 · Cited by 159
Self-citationMenchise, V., Simone, G. D., Alterio, V., Fiore, A. D., Pedone, C., Scozzafava, A., & Supuran, C. T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050333c · Cited by 160
Self-citationCancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site
Singh, S., Lomelino, C. L., Mboge, M. Y., Frost, S. C., & McKENNA, R. V. (2018) · Molecules · doi:10.3390/molecules23051045 · Cited by 156
Dubois, L. J., Douma, K., Supuran, C. T., Chiu, R. K., van Zandvoort, M. A. M. J., Pastoreková, S., Scozzafava, A., Wouters, B. G., & Lambin, P. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.018 · Cited by 154
Self-citationGaraj, V., Puccetti, L., Fasolis, G., Winum, J., Montero, J., Scozzafava, A., Vullo, D., Innocenti, A., & Supuran, C. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.056 · Cited by 149
Self-citationWinum, J., Temperini, C., Cheikh, K. E., Innocenti, A., Vullo, D., Ciattini, S., Montero, J., Scozzafava, A., & Supuran, C. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060807n · Cited by 148
Self-citationCarbonic Anhydrase IX: Regulation and Role in Cancer
Benej, M., Pastoreková, S., & Pastorek, J. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-7359-2_11 · Cited by 148
Self-citationBoleij, A., & Tjalsma, H. (2012) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2012.00218.x · Cited by 153
Carbonic anhydrase inhibitors: Inhibition of the transmembrane isozyme XIV with sulfonamides
Nishimori, I., Vullo, D., Innocenti, A., Scozzafava, A., Mastrolorenzo, A., & Supuran, C. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.06.055 · Cited by 147
Self-citationThe Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
Maresca, A., & Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.040 · Cited by 144
Self-citationDitte, P., Dequiedt, F., Švastová, E., Hulı́ková, A., Ohradanova‐Repic, A., Zaťovičová, M., Csáderová, L., Kopáček, J., Supuran, C. T., Pastoreková, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2520 · Cited by 142
Self-citationHypoxia and cellular metabolism in tumour pathophysiology
Parks, S. K., Cormerais, Y., & Pouysségur, J. (2017) · The Journal of Physiology · doi:10.1113/jp273309 · Cited by 145
Chafe, S. C., Vizeacoumar, F. S., Venkateswaran, G., Nemirovsky, O., Awrey, S. J., Brown, W. S., McDonald, P. C., Carta, F., Metcalfe, A. L., Karasinska, J. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj0364 · Cited by 144
Self-citationTostain, J., Li, G., Gentil‐Perret, A., & Gigante, M. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.020 · Cited by 140
Effects of hypoxia on tumor metabolism
Kim, J., Gao, P., & Dang, C. V. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9060-4 · Cited by 146
Temperini, C., Innocenti, A., Scozzafava, A., Parkkila, S., & Supuran, C. T. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901524f · Cited by 139
Self-citationFunction of carbonic anhydrase IX in glioblastoma multiforme
Proescholdt, M. A., Merrill, M. J., Stoerr, E.-M., Lohmeier, A., Pohl, F., & Brawanski, A. T. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos216 · Cited by 136
Carbonic Anhydrase Inhibitors Drug Design
McKENNA, R. V., & Supuran, C. T. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-7359-2_15 · Cited by 135
Self-citationFiaschi, T., Giannoni, E., Taddei, L., Cirri, P., Marini, A., Pintus, G., Nativi, C., Richichi, B., Scozzafava, A., Carta, F., et al. (2013) · Cell Cycle · doi:10.4161/cc.24902 · Cited by 135
Self-citationExpression of Carbonic Anhydrase IX in Astrocytic Tumors Predicts Poor Prognosis
Haapasalo, J. A., Nordfors, K., Hilvo, M., Rantala, I., Soini, Y., Parkkila, A., Pastoreková, S., Pastorek, J., Parkkila, S., & Haapasalo, H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0848 · Cited by 134
Self-citationExploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery
Supuran, C. T. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1743676 · Cited by 132
Self-citationThe therapeutic implications of immunosuppressive tumor aerobic glycolysis
Reinfeld, B. I., Rathmell, W. K., Kim, T. K., & Rathmell, J. C. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00727-3 · Cited by 135
Innocenti, A., Vullo, D., Scozzafava, A., & Supuran, C. T. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.06.013 · Cited by 129
Self-citationInsights towards sulfonamide drug specificity in α-carbonic anhydrases
Aggarwal, M., Kondeti, B., & McKENNA, R. V. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.08.019 · Cited by 127
Alle, M., Reddy, G. B., Kim, T., Park, S. H., Lee, S. H., & Kim, J. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115511 · Cited by 124
Supuran, C. T. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129411 · Cited by 124
Self-citationNocentini, A., Angeli, A., Carta, F., Winum, J., Žalubovskis, R., Carradori, S., Capasso, C., Donald, W. A., & Supuran, C. T. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1882453 · Cited by 123
Self-citationMorris, J. C., Chiche, J., Grellier, C., Lopez, M., Bornaghi, L. F., Maresca, A., Supuran, C. T., Pouysségur, J., & Poulsen, S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200892s · Cited by 122
Self-citationAcidic tumor microenvironment in human melanoma
Böhme, I., & Bosserhoff, A. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12495 · Cited by 126
Can, D., Spingler, B., Schmutz, P., Mendes, F., Raposinho, P., Fernandes, C., Carta, F., Innocenti, A., Santos, I., Supuran, C. T., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107333 · Cited by 121
Self-citationPuccetti, L., Fasolis, G., Vullo, D., CHOHAN, Z. H., Scozzafava, A., & Supuran, C. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.055 · Cited by 120
Self-citationHypoxia and the phenomenon of immune exclusion
Pietrobon, V., & Marincola, F. M. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02667-4 · Cited by 119
Cancer nanomedicines targeting tumor extracellular pH
Li, T. X., & Bae, Y. H. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.10.039 · Cited by 123
Moeker, J., Peat, T. S., Bornaghi, L. F., Vullo, D., Supuran, C. T., & Poulsen, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500255y · Cited by 121
Self-citationCarta, F., Maresca, A., Scozzafava, A., & Supuran, C. T. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.02.014 · Cited by 118
Self-citationCarbonic Anhydrase IX as an Imaging and Therapeutic Target for Tumors and Metastases
Tafreshi, N. K., Lloyd, M. C., Bui, M. M., Gillies, R. J., & Morse, D. L. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-7359-2_12 · Cited by 121
Asgharzadeh, M. R., Barar, J., Pourseif, M. M., Eskandani, M., Niya, M. J., Mashayekhi, M. R., & Omidi, Y. (2017) · Bioimpacts · doi:10.15171/bi.2017.15 · Cited by 118
Revisiting the Warburg Effect with Focus on Lactate
Kocianova, E., Piatrikova, V., & Golias, T. (2022) · Cancers · doi:10.3390/cancers14246028 · Cited by 124
Shi, J., Guo-bao, W., Chen, H., Zhong, W., Qiu, X., & Xing, M. M. Q. (2014) · Polymer Chemistry · doi:10.1039/c4py00631c · Cited by 119
Pettersen, E. O., Ebbesen, P., Gieling, R. G., Williams, K. J., Dubois, L. J., Lambin, P., Ward, C., Meehan, J., Kunkler, I. H., Langdon, S. P., et al. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.966704 · Cited by 116
Self-citationUpdate on carbonic anhydrase inhibitors: a patent review (2008 – 2011)
Aggarwal, M., & McKENNA, R. V. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.707646 · Cited by 113
Hypoxia in cancer cell metabolism and pH regulation
Brahimi-Horn, M. C., & Pouysségur, J. (2007) · Essays in Biochemistry · doi:10.1042/bse0430165 · Cited by 113
How protons pave the way to aggressive cancers
Swietach, P., Boedtkjer, E., & Pedersen, S. F. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00628-9 · Cited by 118
Exosomes expressing carbonic anhydrase 9 promote angiogenesis
Horie, K., Kawakami, K., Fujita, Y., Sugaya, M., Kameyama, K., Mizutani, K., Deguchi, T., & Ito, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.107 · Cited by 111
Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors
Supuran, C. T. (2020) · Journal of Experimental Pharmacology · doi:10.2147/jep.s265620 · Cited by 111
Self-citationMolecular mechanisms of carbonic anhydrase IX‐mediated pH regulation under hypoxia
Pastoreková, S., Ratcliffe, P. J., & Pastorek, J. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07642.x · Cited by 111
Self-citationStiti, M., Cecchi, A., Rami, M., Abdaoui, M., Barragan‐Montero, V., Scozzafava, A., Guari≠, Y., Winum, J., & Supuran, C. T. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805558k · Cited by 110
Self-citationCarbonic anhydrase IX: An atypical target for innovative therapies in cancer
Ronca, R., & Supuran, C. T. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189120 · Cited by 110
Self-citationParks, S. K., & Pouysségur, J. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24930 · Cited by 110
Simone, G. D., Vitale, R. M., Fiore, A. D., Pedone, C., Scozzafava, A., Montero, J., Winum, J., & Supuran, C. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060531j · Cited by 106
Self-citationHypoxia Helps Glioma to Fight Therapy
Murphy, V. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166637 · Cited by 111
Ahlskog, J., Schliemann, C., Mårlind, J., Qureshi, U., Ammar, A., Pedley, R. B., & Neri, D. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605200 · Cited by 110
Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited—old leads for new applications?
Temperini, C., Cecchi, A., Scozzafava, A., & Supuran, C. T. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b800767e · Cited by 104
Self-citationIlié, M., Hofman, V., Ortholan, C., Ammadi, R. E., Bonnetaud, C., Havet, K., Vénissac, N., Mouroux, J., Mazure, N. M., Pouysségur, J., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25491 · Cited by 108
The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration
Csáderová, L., Debreova, M., Radvák, P., Stano, M., Vrestiakova, M., Kopáček, J., Pastoreková, S., & Švastová, E. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00271 · Cited by 102
Self-citationCarta, F., Garaj, V., Maresca, A., Wagner, J. M., Avvaru, B. S., Robbins, A. H., Scozzafava, A., McKENNA, R. V., & Supuran, C. T. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.005 · Cited by 100
Self-citationZaťovičová, M., Sedlakova, O., Švastová, E., Ohradanova‐Repic, A., ČIAMPOR, F. J., Arribas, J., Pastorek, J., & Pastoreková, S. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602861 · Cited by 100
Self-citationGrandāne, A., Tanç, M., Mannelli, L. D. C., Carta, F., Ghelardini, C., Žalubovskis, R., & Supuran, C. T. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00523 · Cited by 99
Self-citationFiore, A. D., Pedone, C., D’Ambrosio, K., Scozzafava, A., Simone, G. D., & Supuran, C. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.040 · Cited by 99
Self-citationExpression of transmembrane carbonic anhydrases IX and XII in ovarian tumours
Hynninen, P., Vaskivuo, L., Saarnio, J., Haapasalo, H. K., Kivelä, J., Pastoreková, S., Pastorek, J., Waheed, A., Sly, W. S., Puistola, U., et al. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02523.x · Cited by 101
Self-citationNanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
Pan, Y., Liu, L., Mou, X., & Cai, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c07763 · Cited by 98
Drug Design of Zinc‐Enzyme Inhibitors
Supuran, C., & Winum, J.-Y. (2009) · Wiley eBooks · doi:10.1002/9780470508169 · Cited by 263
Dubois, L. J., Peeters, S. G. J. A., van Kuijk, S. J. A., Yaromina, A., Lieuwes, N. G., Saraya, R., Biemans, R., Rami, M., Parvathaneni, N. K., Vullo, D., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.018 · Cited by 94
Self-citationAkurathi, V., Dubois, L. J., Lieuwes, N. G., Chitneni, S. K., Cleynhens, B. J., Vullo, D., Supuran, C. T., Verbruggen, A., Lambin, P., & Bormans, G. M. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.02.006 · Cited by 92
Self-citationCarbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis
Andreucci, E., Peppicelli, S., Carta, F., Brisotto, G., Biscontin, E., Ruzzolini, J., Bianchini, F., Biagioni, A., Supuran, C. T., & Calorini, L. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1590-9 · Cited by 92
Self-citationAnti-Cancer Peptides: Status and Future Prospects
Ghaly, G., Tallima, H., Dabbish, E., ElDin, N. B., El‐Rahman, M. K. A., Ibrahim, M. A. A., & Shoeib, T. (2023) · Molecules · doi:10.3390/molecules28031148 · Cited by 92
Baráthová, M., Takáčová, M., Holotnakova, T., Gibadulinová, A., Ohradanova‐Repic, A., Zaťovičová, M., Hulı́ková, A., Kopáček, J., Parkkila, S., Supuran, C. T., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604111 · Cited by 92
Self-citationInhibition of carbonic anhydrase IX as a novel anticancer mechanism
Supuran, C. T. (2012) · World Journal of Clinical Oncology · doi:10.5306/wjco.v3.i7.98 · Cited by 91
Self-citationDahinden, C., Ingold, B., Wild, P. J., Boysen, G., Luu, V.-D., Montani, M., Kristiansen, G., Sulser, T., Bühlmann, P., Moch, H., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0260 · Cited by 91
Physiological Functions of the Alpha Class of Carbonic Anhydrases
Frost, S. C. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-7359-2_2 · Cited by 91
Yeung, S. J., She, M., Yang, H., Pan, J., Sun, L., & Chaplin, D. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0027 · Cited by 90
Obacz, J., Pastoreková, S., Vojtesek, B., & Hrstka, R. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-93 · Cited by 92
Self-citationThe acetyl-CoA carboxylase enzyme: a target for cancer therapy?
Wang, C., Ma, J., Zhang, N., Yang, Q., Jin, Y., & Wang, Y. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1038246 · Cited by 87
Influence of Tumor pH on Therapeutic Response
Song, C. W., Griffin, R. J., & Park, H. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_2 · Cited by 87
Gieling, R. G., Parker, C. A., Costa, L. A. D., Robertson, N., Harris, A. L., Stratford, I. J., & Williams, K. J. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.736979 · Cited by 92
Hulı́ková, A., Vaughan‐Jones, R. D., & Swietach, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219899 · Cited by 87
Self-citationThe Potential Role of Intrinsic Hypoxia Markers as Prognostic Variables in Cancer
Moon, E. J., Brizel, D. M., Chi, J., & Dewhirst, M. W. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1623 · Cited by 88
Carbonic anhydrases as disease markers
Zamanova, S., Shabana, A. M., Mondal, U. K., & Ilies, M. A. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1629419 · Cited by 85
Tafreshi, N. K., Lloyd, M. C., Proemsey, J. B., Bui, M. M., Kim, J., Gillies, R. J., & Morse, D. L. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0885-x · Cited by 87
Petibois, C., Estieu‐Gionnet, K., Gonçalves, M., Perromat, A., Moenner, M., & Déléris, G. (2006) · The Analyst · doi:10.1039/b518076g · Cited by 85
Hewitt, C. S., Abutaleb, N. S., Elhassanny, A. E. M., Nocentini, A., Cao, X., Amos, D. P., Youse, M. S., Holly, K. J., Marapaka, A. K., An, W., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00055 · Cited by 84
Self-citationDrug distribution in tumors: Mechanisms, role in drug resistance, and methods for modification
Paolo, A. D., & Bocci, G. (2007) · Current Oncology Reports · doi:10.1007/s11912-007-0006-3 · Cited by 86
Fahim, A. M., & Shalaby, M. A. (2018) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2018.08.087 · Cited by 83
The sulfamide motif in the design of enzyme inhibitors
Winum, J., Scozzafava, A., Montero, J., & Supuran, C. T. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.1.27 · Cited by 83
Self-citationGenis, C., Sippel, K. H., Case, N., Cao, W., Avvaru, B. S., Tartaglia, L. J., Lakshmanan Govindasamy, A., Tu, C., Agbandje‐McKenna, M., Silverman, D. N., et al. (2009) · Biochemistry · doi:10.1021/bi802035f · Cited by 82
Kopáček, J., Baráthová, M., Dequiedt, F., Sepelakova, J., Kettmann, R., Pastorek, J., & Pastoreková, S. (2005) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2005.03.003 · Cited by 81
Self-citationBao, B., Groves, K., Zhang, J., Handy, E. L., Kennedy, P., Cuneo, G. J., Supuran, C. T., Yared, W., Rajopadhye, M., & Peterson, J. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050860 · Cited by 81
Self-citationAbdel‐Hamid, M. K., ABDEL‐HAFEZ, A. A., El‐Koussi, N. A., Mahfouz, N. M., Innocenti, A., & Supuran, C. T. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.07.044 · Cited by 80
Self-citationInhibition of Carbonic Anhydrases with Glycosyltriazole Benzene Sulfonamides
Wilkinson, B. L., Innocenti, A., Vullo, D., Supuran, C. T., & Poulsen, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701426t · Cited by 79
Self-citationGenerali, D., Fox, S. B., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Wigfield, S., Bruzzi, P., Bersiga, A., Allevi, G., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01216 · Cited by 79
7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors
Tanç, M., Carta, F., Bozdağ, M., Scozzafava, A., & Supuran, C. T. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.032 · Cited by 77
Self-citationLogozzi, M., Capasso, C., Raimo, R. D., Prete, S. D., Mizzoni, D., Falchi, M., Supuran, C. T., & Fais, S. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1538980 · Cited by 79
Self-citationInnocenti, A., Pastoreková, S., Pastorek, J., Scozzafava, A., Simone, G. D., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.088 · Cited by 76
Self-citationHypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export
Parks, S. K., Cormerais, Y., Marchiq, I., & Pouysségur, J. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.12.001 · Cited by 80
Multi- and polypharmacology of carbonic anhydrase inhibitors
Supuran, C. T. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001125 · Cited by 75
Self-citationCarbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors
Kalinin, S., Михайловна, М. А., Sharonova, T. V., Sharoyko, V. V., Bunev, A. S., Supuran, C. T., & Krasavin, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413405 · Cited by 78
Self-citationAlmajan, G. L., Innocenti, A., Puccetti, L., Manole, G., Bărbuceanu, Ș. F., Şaramet, I., Scozzafava, A., & Supuran, C. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.088 · Cited by 74
Self-citationDoyen, J., Parks, S. K., Marcié, S., Pouysségur, J., & Chiche, J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2012.00199 · Cited by 71
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness
Ward, C., Meehan, J., Gray, M., Kunkler, I. H., Langdon, S. P., & Argyle, D. J. (2018) · Metabolites · doi:10.3390/metabo8010013 · Cited by 76
Metadata
- Authors
- Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., & Pastoreková, S.
- Affiliations
- Slovak Academy of Sciences (SK)
- University of Florence (IT)
- ORCID
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2004-10-28
- Volume
- 577
- Issue
- 3
- Pages
- 439-445
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W1990331048
- Cited by
- 711
- References
- 32
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 17 · 2023: 31 · 2022: 22 · 2021: 33 · 2020: 37 · 2019: 27 · 2018: 35 · 2017: 39 · 2016: 22 · 2015: 47 · 2014: 46 · 2013: 43 · 2012: 36
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- Bayer HealthCare
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- carbonic anhydrase IX, tumor hypoxia, extracellular pH, tumor acidosis, sulfonamide inhibitors, glycolysis, tumor progression
- MeSH terms
- Carbonic Anhydrase IX, Acidosis, Animals, Antigens, Neoplasm, Binding Sites, Carbonic Anhydrases, Cell Line, Cloning, Molecular, Culture Media, Dogs, Enzyme Inhibitors, HeLa Cells, Humans, Hydrogen-Ion Concentration, Isoenzymes, Precipitin Tests, Sulfonamides, Time Factors, Biomarkers, Tumor, Molecular Structure, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Sequence Deletion, Protein Structure, Tertiary, Biotinylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review